ARUNI WILSON

Dr. ARUNI WILSON


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2019 in Pathogens
Verified
Journal Article
Open access
PDF file
PSPreethi Sudhakara
Preethi Sudhakara
ISIyappan Sellamuthu
Iyappan Sellamuthu
AWARUNI WILSON
ARUNI WILSON
Human oral microbiome and dysbiotic infections have been recently evidently identified. One of the major reasons for such dysbiosis is impairment of the immune system. Periodontitis is a chronic inflammatory disease affecting the tissues that surround and support the teeth. In the United States., approximately 65 million people are affected by this condition. Its occurrence is also associated with many important systemic diseases such as cardiovascular disease, rheumatoid arthritis, and Alzheimer’s disease. Among the most important etiologies of periodontitis is Porphyromonas gingivalis, a keystone bacterial pathogen. Keystone pathogens can orchestrate inflammatory disease by remodeling a normally benign microbiota causing imbalance between normal and pathogenic microbiota (dysbiosis). The important characteristics of P. gingivalis causing dysbiosis are its virulence factors which cause effective subversion of host defenses to its advantage allowing other pathogens to grow. Some of the mechanisms involved in these processes are still not well-understood. However, various microbial strategies target host sialoglycoproteins for immune dysregulation. In addition, the enzymes that break down sialoglycoproteins and sialoglycans are the “sialoglycoproteases”, resulting in exposed terminal sialic acid. This process could lead to pathogen-toll like receptor (TLR) interactions mediated through sialic acid receptor ligand mechanisms. Assessing the function of P. gingivalis sialoglycoproteases, could pave the way to designing carbohydrate analogues and sialic acid mimetics to serve as drug targets.

22 April 2022 in Advances in Materials Science and Engineering
Verified
Journal Article
Open access
PDF file
JJJerrine Joseph
Jerrine Joseph
KMKaari Manigundan
Kaari Manigundan
MAMARY SHAMYA SHAMYA A
MARY SHAMYA SHAMYA A
MRManikkam Radhakrishnan
Manikkam Radhakrishnan
GVGopikrishnan Venugopal
Gopikrishnan Venugopal
VSVelmurugan Shanmugam
Velmurugan Shanmugam
Biowaste originating from aquaculture sector represents a potential feedstock to produce value-added substances and materials like chitin and chitosan. They are the long chain polymers of N-acetylglucosamine polymers with huge industrial and biomedical significance. Chitin has long been recognized as a useful biomaterial for drug delivery and neurological therapy. Similarly, chitosan oligosaccharide, a short chain polymer derived from chitin/chitosan, has been identified for its potential biomedical applications, including antibacterial, anti-inflammatory, and anti-Alzheimer action. Chitosan nanoparticles are also used extensively in biomedical applications. Here we have critically summarized various methods for the extraction of chitin, chitosan, and chitooligossacharides and chitosan nanoparticle preparation and their diverse biomedical applications.

1 January 2023 in Journal of Applied Biology & Biotechnology
Verified
Journal Article
Open access
PDF file
CPChirayu Padhiar
Chirayu Padhiar
MMMuthuraman Muthuchamy
Muthuraman Muthuchamy
ADArvind Kumar Dhanraj
Arvind Kumar Dhanraj
SRSrividhya Raghavan
Srividhya Raghavan
MAMayur Abhaya
Mayur Abhaya
AWARUNI WILSON
ARUNI WILSON
Human umbilical cord tissue (hUCT) is one of the non-invasive sources of mesenchymal stem cells (MSCs) and comprises similar cell surface markers as that of bone marrow-derived MSCs. Although the MSCs from hUCT are known to have several therapeutic advantages and are found to be implicated in numerous clinical trials, there is often a significant requirement for the expansion of the MSCs at the laboratory level before transplantation. In this regard, the main objective of this study is to compare the variations between cells expanded from single donors and cells pooled from multiple donors. For this, (i) the cells from three individual donors were sequentially expanded up to ten passages (P10) and (ii) the cells from three donors were pooled at P1 and P2 stages, respectively, and expanded sequentially till P10. The expanded cells were characterized for surface markers, trilineage differentiation, and mutational variations at each passage. Furthermore, the cells were pooled and expanded in the 3D stir tank reactor at the P4 passage and checked for variations. Results indicate that the cells at each passage level from both individual and pooled donors were normal concerning the expression of the cell surface markers such as CD90, CD105, CD31, differentiation into osteocyte, chondrocyte, and adipocyte, and no abnormalities were observed in karyotyping. Furthermore, the characteristics of cells expanded in the stirred tank bioreactor were found to be normal. Thus, we conclude that the MSCs can be pooled from the different donors and expanded to the desired numbers before transplantation as there are no variations found at the mutational and characterization levels.

1 September 2020 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Closed access
JJJerrine Joseph
Jerrine Joseph
CEC Emmanuel
C Emmanuel
ASArumugam Suresh
Arumugam Suresh
APAnand Parathasarthy
Anand Parathasarthy
AWARUNI WILSON
ARUNI WILSON
Planum sphenoidale meningiomas are rare slow growing tumours that impair cognition and lead to behavioural changes. Other common presentations of this condition include persistent headache followed by vision diminution. Dismissing cognitive impairment and behavioural changes as part of dementia, depression, or aging might lead to loss of opportunity to treatment. The common symptoms manifested in sphenoid (spheno-orbital) wing meningioma is bulging of the eyes which may be painless, visual impairment and ocular paresis. Headache is also a common symptom, in addition to ptosis. Variants of the clinical syndrome include the following: Eye swelling and hearing loss, optic atropy, Kennedy syndrome and mental changes. The replace the word with- present patient experienced severe headache and when went for a routine eye check-up where the loss of vision in the left eye was confirmed, through the field test. The MRI confirmed the tumour presence. Though the diagnosis was informed it took one year to convince the patient for the surgery. Hence, the author wishes to emphasise the role of tumour support systems. Physician's serve as patients' first point of entry into the health care system and as the continuing focal point for all necessary health care services along with their team they play a vital role in convincing patients from postdiagnosis to surgery and recovery.

28 August 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SASujithra Appavu
Sujithra Appavu
AWARUNI WILSON
ARUNI WILSON
MSMukinkumar Sonai
Mukinkumar Sonai
VAVinoth Appavu
Vinoth Appavu
Background: Advanced maternal age (AMA; > = 35 years) is associated with increased fetal chromosomal risk and is an important indication for invasive prenatal diagnosis. This study evaluates karyotyping and chromosomal microarray analysis (CMA) findings among AMA pregnancies in Tamil Nadu, India. Methods: In this prospective observational study, 2,200 pregnant women aged ≥35 years who underwent amniocentesis between July 2020 and June 2021 were enrolled. Conventional karyotyping was performed in all cases. CMA was performed as a reflex or complementary test when predefined clinical or cytogenetic criteria were present, including ultrasound abnormalities, high-risk screening/NIPT results, abnormal or uncertain karyotype findings, prior adverse pregnancy history suggestive of genetic etiology, parental chromosomal abnormalities, or patient request after counseling. Results: Numerical chromosomal abnormalities were detected in 76/2200 cases (3.5%), and structural abnormalities were detected in 9/2200 cases (0.4%). The total abnormal cytogenetic yield was therefore 85/2200 cases (3.9%) when numerical and structural abnormalities were considered together. Age-stratified analysis showed an increasing trend in chromosomal abnormalities with advancing maternal age, reaching 10.4% in women aged > = 43 years. Cases with additional clinical indications showed higher abnormality rates than simple AMA. CMA was performed in selected cases and contributed to characterization of clinically relevant genomic abnormalities, supporting its role in indicated high-risk AMA pregnancies. Conclusion: The Tamil Nadu cohort provides regional evidence on age-stratified cytogenetic risk in AMA pregnancies and supports the use of clearly defined criteria for integrating CMA with conventional karyotyping in prenatal diagnosis.

12 November 2023
Verified
Journal Article
Open access
PDF file
SASujithra Appavu
Sujithra Appavu
AWARUNI WILSON
ARUNI WILSON
WAWilson Santhosh Kumar Aruni
Wilson Santhosh Kumar Aruni
CPChirayu Padhiar
Chirayu Padhiar
FBFlora Bai
Flora Bai
MNMurugan Nandagopal
Murugan Nandagopal
Background: Prenatal screening for aneuploidy during the first and second trimesters is a part of obstetric care. Because invasive procedures carry a high risk of miscarriage, these screening tests in high-risk pregnancies for aneuploidies are essential for determining the abnormality. The present study aimed to determine the predictive accuracy of prenatal screening tests and USG soft markers concerning maternal age groups, the incidence of chromosomal abnormalities, and the trends of screening tests chosen by obstetricians for women undergoing prenatal chromosome analysis prenatal screening. Methods: 2280 Pregnant women were referred for prenatal screening tests in 2019–2020 by a well-established medical diagnostic laboratory, Lifecell International Private Limited.The sample has been analyzed based on the maternal age, screening tests, clinical indicators, karyotype interpretation, and type of chromosomal abnormalities. All the data were examined with the aid of SPSS 16.0 and EXCEL. Results: 46.40% of women used TMT, 7.28% used DMT, and 3.82% used a combined first-trimester test in the present study. Positive predictive accuracy of the first trimester combined test is the highest (33.33%). Among 2280 women screened positive for aneuploidy based on different prenatal screening procedures, only 149 (6.5%) were found to have an abnormal karyotype, and the remaining 2131(93.5%) had a normal karyotype. USG marker in the absence of biochemical markers can detect considerable aneuploidy risk during the first and second trimesters. Conclusion: The present study shows that in India second trimester prenatal tests are preferred over first-trimester prenatal tests by obstetricians. It shows that biochemical risk estimated in the first and second trimesters does not turn into a high likelihood of chromosomal abnormality in the general population. However, these tests can help informed decision-making in high-risk pregnancies based on maternal age and unfavourable obstetric history. Further confirmation through advanced methods like Chromosomal Microarray (CMA), Whole Genome Sequencing (WGS) is warranted for better diagnostic decisions.